Zevra Therapeutics Stock Price History
| ZVRA Stock | 11.77 0.19 1.64% |
Below is the normalized historical share price chart for Zevra Therapeutics extending back to April 16, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Zevra Therapeutics stands at 11.77, as last reported on the 23rd of July, with the highest price reaching 11.95 and the lowest price hitting 11.65 during the day.
If you're considering investing in Zevra Stock, it is important to understand the factors that can impact its price. Zevra Therapeutics appears to be not too volatile, given 3 months investment horizon. Zevra Therapeutics shows Sharpe Ratio of 0.26, which attests that the company had a 0.26 % return per unit of risk over the last 3 months. By examining Zevra Therapeutics' technical indicators, you can evaluate if the expected return of 0.84% is justified by implied risk. Please utilize Zevra Therapeutics' Market Risk Adjusted Performance of 1.56, downside deviation of 2.7, and Mean Deviation of 2.3 to validate if our risk estimates are consistent with your expectations. At present, Zevra Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 48.6 M, whereas Common Stock is forecasted to decline to 4,750. . At present, Zevra Therapeutics' Price To Sales Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 10.21, whereas Price Earnings Ratio is forecasted to decline to (3.84). Zevra Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of April 2015 | 200 Day MA 8.4617 | 50 Day MA 9.6115 | Beta 1.964 |
Sharpe Ratio = 0.2613
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ZVRA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.2 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.84 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.26 actual daily | 20 80% of assets perform better |
Based on monthly moving average Zevra Therapeutics is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zevra Therapeutics by adding it to a well-diversified portfolio.
Price Book 15.435 | Enterprise Value Ebitda (4.24) | Price Sales 15.6004 | Shares Float 46 M | Wall Street Target Price 22.75 |
Zevra Therapeutics Stock Price History Chart
There are several ways to analyze Zevra Stock price data. The simplest method is using a basic Zevra candlestick price chart, which shows Zevra Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 14, 2025 | 12.79 |
| Lowest Price | April 25, 2025 | 7.2 |
Zevra Therapeutics July 23, 2025 Stock Price Synopsis
Various analyses of Zevra Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Zevra Stock. It can be used to describe the percentage change in the price of Zevra Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Zevra Stock.| Zevra Therapeutics Price Daily Balance Of Power | 0.63 | |
| Zevra Therapeutics Accumulation Distribution | 25,251 | |
| Zevra Therapeutics Price Rate Of Daily Change | 1.02 | |
| Zevra Therapeutics Price Action Indicator | 0.06 |
Zevra Therapeutics July 23, 2025 Stock Price Analysis
Zevra Stock Price History Data
The price series of Zevra Therapeutics for the period between Thu, Apr 24, 2025 and Wed, Jul 23, 2025 has a statistical range of 5.92 with a coefficient of variation of 17.72. The daily prices for the period are distributed with arithmetic mean of 9.07. The median price for the last 90 days is 8.83. The company experienced 1:16 stock split on 28th of December 2020. Zevra Therapeutics paid out dividends to its shareholders on 2020-12-28.| Open | High | Low | Close | Volume | ||
07/23/2025 | 11.68 | 11.95 | 11.65 | 11.77 | 1,005,834 | |
07/22/2025 | 11.72 | 11.83 | 11.49 | 11.58 | 708,660 | |
| 07/21/2025 | 12.14 | 12.21 | 11.64 | 11.73 | 1,133,054 | |
| 07/18/2025 | 12.77 | 12.80 | 12.01 | 12.07 | 1,197,436 | |
07/17/2025 | 12.32 | 12.75 | 12.21 | 12.66 | 1,494,100 | |
| 07/16/2025 | 12.83 | 12.89 | 12.17 | 12.32 | 1,605,749 | |
07/15/2025 | 12.79 | 13.16 | 12.54 | 12.79 | 1,700,800 | |
07/14/2025 | 12.67 | 12.90 | 12.34 | 12.79 | 2,249,956 | |
07/11/2025 | 12.09 | 12.55 | 11.89 | 12.53 | 1,626,200 | |
| 07/10/2025 | 11.94 | 12.37 | 11.75 | 12.02 | 1,687,454 | |
07/09/2025 | 11.73 | 11.84 | 11.48 | 11.56 | 1,000,800 | |
07/08/2025 | 11.31 | 11.59 | 11.06 | 11.55 | 1,433,942 | |
07/07/2025 | 9.78 | 11.49 | 9.78 | 11.27 | 4,888,089 | |
07/03/2025 | 9.41 | 10.03 | 9.29 | 9.74 | 1,176,800 | |
| 07/02/2025 | 9.21 | 9.63 | 9.01 | 9.41 | 1,564,811 | |
07/01/2025 | 8.71 | 8.95 | 8.58 | 8.95 | 678,437 | |
06/30/2025 | 9.03 | 9.07 | 8.81 | 8.81 | 415,059 | |
| 06/27/2025 | 9.25 | 9.25 | 8.89 | 9.00 | 909,746 | |
| 06/26/2025 | 9.30 | 9.39 | 9.11 | 9.28 | 415,661 | |
06/25/2025 | 9.16 | 9.43 | 9.06 | 9.33 | 364,482 | |
06/24/2025 | 9.07 | 9.20 | 8.97 | 9.15 | 309,328 | |
06/23/2025 | 9.00 | 9.03 | 8.83 | 9.00 | 358,500 | |
| 06/20/2025 | 9.17 | 9.18 | 8.96 | 9.04 | 559,500 | |
06/18/2025 | 8.79 | 9.14 | 8.71 | 9.07 | 422,003 | |
06/17/2025 | 9.05 | 9.21 | 8.81 | 8.81 | 453,114 | |
06/16/2025 | 9.17 | 9.37 | 8.99 | 9.13 | 564,500 | |
06/13/2025 | 9.24 | 9.33 | 9.07 | 9.13 | 527,614 | |
06/12/2025 | 9.37 | 9.50 | 9.29 | 9.37 | 480,100 | |
06/11/2025 | 9.35 | 9.62 | 9.28 | 9.38 | 664,500 | |
06/10/2025 | 9.25 | 9.42 | 9.05 | 9.28 | 613,637 | |
06/09/2025 | 9.40 | 9.41 | 9.02 | 9.19 | 722,789 | |
06/06/2025 | 8.97 | 9.38 | 8.93 | 9.26 | 1,339,800 | |
06/05/2025 | 8.98 | 9.11 | 8.78 | 8.83 | 491,079 | |
06/04/2025 | 8.81 | 9.06 | 8.78 | 8.95 | 512,800 | |
06/03/2025 | 8.68 | 8.94 | 8.59 | 8.87 | 634,069 | |
06/02/2025 | 8.61 | 8.81 | 8.54 | 8.66 | 398,800 | |
05/30/2025 | 8.63 | 8.63 | 8.38 | 8.55 | 354,577 | |
| 05/29/2025 | 8.37 | 8.62 | 8.27 | 8.62 | 436,400 | |
05/28/2025 | 8.44 | 8.47 | 8.21 | 8.33 | 427,621 | |
05/27/2025 | 8.74 | 8.78 | 8.40 | 8.45 | 489,560 | |
05/23/2025 | 8.45 | 8.68 | 8.43 | 8.65 | 376,000 | |
05/22/2025 | 8.60 | 8.67 | 8.49 | 8.57 | 452,478 | |
05/21/2025 | 8.55 | 8.84 | 8.41 | 8.66 | 535,249 | |
05/20/2025 | 8.91 | 8.91 | 8.57 | 8.61 | 766,838 | |
05/19/2025 | 8.57 | 8.91 | 8.51 | 8.91 | 550,792 | |
05/16/2025 | 8.41 | 8.72 | 8.37 | 8.66 | 1,462,225 | |
05/15/2025 | 8.17 | 8.43 | 7.90 | 8.43 | 726,974 | |
| 05/14/2025 | 8.50 | 8.50 | 7.77 | 8.14 | 1,664,663 | |
05/13/2025 | 7.83 | 8.03 | 7.63 | 7.87 | 662,000 | |
05/12/2025 | 8.02 | 8.11 | 7.72 | 7.75 | 464,172 | |
05/09/2025 | 7.82 | 8.08 | 7.82 | 7.87 | 363,500 | |
05/08/2025 | 7.50 | 7.96 | 7.31 | 7.79 | 452,479 | |
05/07/2025 | 7.45 | 7.57 | 7.26 | 7.51 | 437,800 | |
05/06/2025 | 7.90 | 8.03 | 7.40 | 7.40 | 416,862 | |
05/05/2025 | 7.93 | 8.09 | 7.86 | 8.00 | 399,800 | |
05/02/2025 | 7.71 | 8.09 | 7.66 | 8.00 | 593,590 | |
05/01/2025 | 7.30 | 7.90 | 7.19 | 7.64 | 728,343 | |
04/30/2025 | 7.17 | 7.41 | 7.15 | 7.33 | 260,937 | |
04/29/2025 | 7.25 | 7.35 | 7.11 | 7.23 | 319,714 | |
04/28/2025 | 7.22 | 7.26 | 7.15 | 7.20 | 244,651 | |
04/25/2025 | 7.20 | 7.21 | 7.04 | 7.20 | 366,144 |
About Zevra Therapeutics Stock history
Zevra Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Zevra is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Zevra Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Zevra Therapeutics stock prices may prove useful in developing a viable investing in Zevra Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 46.3 M | 48.6 M | |
| Net Loss | -37.4 M | -39.3 M |
Zevra Therapeutics Quarterly Net Working Capital |
|
Zevra Therapeutics Stock Technical Analysis
Zevra Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
| All Next | Launch Module |
Zevra Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Zevra Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Zevra Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Zevra to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.2316 | |||
| Jensen Alpha | 0.7087 | |||
| Total Risk Alpha | 0.1911 | |||
| Sortino Ratio | 0.2316 | |||
| Treynor Ratio | 1.55 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Zevra Stock analysis
When running Zevra Therapeutics' price analysis, check to measure Zevra Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zevra Therapeutics is operating at the current time. Most of Zevra Therapeutics' value examination focuses on studying past and present price action to predict the probability of Zevra Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zevra Therapeutics' price. Additionally, you may evaluate how the addition of Zevra Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |